上腹部手术成人术后预防性无创通气:系统评价与Meta分析
该系统评价与Meta分析检索PubMed、Embase、CINAHL、CENTRAL和Scopus(从建库至2021年5月17日),纳入17项随机对照试验、共6108例上腹部手术成人患者。结果显示,与标准治疗相比,术后预防性无创通气/持续气道正压通气未显著降低术后肺部并发症(RR 0.89,95%CI 0.78-1.01,极低确定性),在高危患者中亦然(RR 0.91,95%CI 0.77-1.07,极低确定性)。亚组分析未发现某种干预方式更优,持续气道正压通气(RR 0.90,95%CI 0.79-1.04)、无创通气(RR 0.68,95%CI 0.41-1.13)、持续无创通气/持续气道正压通气(RR 0.90,95%CI 0.77-1.05)及间歇无创通气/持续气道正压通气(RR 0.66,95%CI 0.39-1.10)与标准治疗相比均无显著获益。作者认为,上腹部手术后常规预防性无创通气或持续气道正压通气可能不能有效减少术后肺部并发症。
要点
- 上腹部手术后预防性无创通气/持续气道正压通气未显著降低术后肺部并发症(RR 0.89,95%CI 0.78-1.01,极低确定性)。
- 在高危患者中同样未显著获益(RR 0.91,95%CI 0.77-1.07,极低确定性)。
- 与标准治疗相比,持续气道正压通气(RR 0.90,95%CI 0.79-1.04)、无创通气(RR 0.68,95%CI 0.41-1.13)均无显著获益。
- 持续(RR 0.90,95%CI 0.77-1.05)与间歇(RR 0.66,95%CI 0.39-1.10)无创通气/持续气道正压通气与标准治疗相比均无显著获益。
- 未发现某种无创通气或持续气道正压通气方式优于其他方式。
适用人群与场景
- 接受上腹部手术的成人患者,包括经识别为术后肺部并发症风险较高的患者。
研究设计与关键结果
- 系统评价与Meta分析纳入17项随机对照试验、共6108例患者。
- 预防性无创通气/持续气道正压通气与标准治疗相比,术后肺部并发症风险比RR 0.89(95%CI 0.78-1.01),极低确定性,未达统计学显著。
- 在高危患者中,RR 0.91(95%CI 0.77-1.07),极低确定性,未达统计学显著。
- 持续气道正压通气与标准治疗相比,RR 0.90(95%CI 0.79-1.04),极低确定性,未达统计学显著。
- 无创通气与标准治疗相比,RR 0.68(95%CI 0.41-1.13),极低确定性,未达统计学显著。
- 持续无创通气/持续气道正压通气与标准治疗相比,RR 0.90(95%CI 0.77-1.05),极低确定性,未达统计学显著。
- 间歇无创通气/持续气道正压通气与标准治疗相比,RR 0.66(95%CI 0.39-1.10),极低确定性,未达统计学显著。
- 未发现某种干预方式优于其他方式。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析,纳入随机对照试验。
- 采用PEDro量表评估个体研究偏倚风险,采用GRADE框架评估结局确定性。
- 所有主要比较的结局确定性均为极低。
对床旁实践的改变
- 作者认为,上腹部手术后常规提供预防性无创通气或持续气道正压通气可能不能有效减少术后肺部并发症,包括在高危患者中。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Postoperative pulmonary complications (PPCs) are a leading cause of morbidity and mortality following upper abdominal surgery. Applying either noninvasive ventilation (NIV) or continuous positive airway pressure (CPAP) in the early postoperative period is suggested to prevent PPC. We aimed to assess whether postoperative NIV or CPAP or both prevent PPCs compared with standard care in adults undergoing upper abdominal surgery, including in those identified at higher PPC risk. Additionally, the different interventions used were evaluated to assess whether there is a superior approach.
DATA SOURCES: We searched PubMed, Embase' CINAHL, CENTRAL, and Scopus from inception to May 17, 2021.
STUDY SELECTION: We performed a systematic search of the literature for randomized controlled trials evaluating prophylactic NIV and/or CPAP in the postoperative period.
DATA EXTRACTION: Two authors independently performed study selection and data extraction. Individual study risk of bias was assessed using the PEDro scale, and certainty in outcomes was assessed using the Grading of Recommendations Assessment, Development, and Evaluation framework.
DATA SYNTHESIS: We included 17 studies enrolling 6,108 patients. No significant benefit was demonstrated for postoperative NIV/CPAP to reduce PPC (risk ratio [RR], 0.89; 95% CI, 0.78-1.01; very low certainty), including in adults identified at higher PPC risk (RR, 0.91; 95% CI, 0.77-1.07; very low certainty). No intervention approach was identified as superior, and no significant benefit was demonstrated when comparing: 1) CPAP (RR, 0.90; 95% CI, 0.79-1.04; very low certainty), 2) NIV (RR, 0.68; 95% CI, 0.41-1.13; very low certainty), 3) continuous NIV/CPAP (RR, 0.90; 95% CI, 0.77-1.05; very low certainty), or 4) intermittent NIV/CPAP (RR, 0.66; 95% CI, 0.39-1.10; very low certainty) to standard care.
CONCLUSIONS: These findings suggest routine provision of either prophylactic NIV or CPAP following upper abdominal surgery may not be effective to reduce PPCs' including in those identified at higher risk.
参考来源
- Lockstone J, Denehy L, Truong D, et al. Prophylactic Postoperative Noninvasive Ventilation in Adults Undergoing Upper Abdominal Surgery: A Systematic Review and Meta-Analysis. Crit Care Med. 2022. PMID: 35881511. doi:10.1097/CCM.0000000000005628
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。